Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Patients with chronic heart failure (HF) are at increased risk of both fatal and nonfatal major adverse cardiovascular events. We used data from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) trials to assess the influence of nonfatal hospitalizations fo...

Full description

Saved in:

Bibliographic Details
Published in:	Circulation (New York, N.Y.) Vol. 116; no. 13; p. 1482
Main Authors:	Solomon, Scott D, Dobson, Joanna, Pocock, Stuart, Skali, Hicham, McMurray, John J V, Granger, Christopher B, Yusuf, Salim, Swedberg, Karl, Young, James B, Michelson, Eric L, Pfeffer, Marc A
Format:	Journal Article
Language:	English
Published:	United States 25.09.2007
Subjects:	Aftercare Aged Aged, 80 and over Angiotensin II Type 1 Receptor Blockers - therapeutic use Benzimidazoles - therapeutic use Death, Sudden, Cardiac - epidemiology Disease Progression Female Follow-Up Studies Heart Failure - drug therapy Heart Failure - mortality Hospitalization - statistics & numerical data Humans Male Middle Aged Proportional Hazards Models Randomized Controlled Trials as Topic - statistics & numerical data Survival Analysis Tetrazoles - therapeutic use
ISSN:	1524-4539, 1524-4539
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!